DSM is mulling the next step in its Vision 2010 strategy and has
announced that it is in discussions with Sociedad Química y Minera
de Chile over the sale of its Minera iodine unit.
The Dutch life science company this week presented its sustainable
strategy, emphasising the company's progress in the fields of
'People, Planet and Profit'.
Reporting a 1 per cent drop in sales over 2002 and a significantly
lower net income, German fine chemicals group Degussa predicted
sales in core operations should rise to around €11.5 billion for
2003.
Dutch speciality chemicals company DSM continues on its steady path
to growth with the announcement today that operating profit for
2002 reached €383 million, a 14 per cent rise on 2001, thanks in
part to 6 per cent autonomous volume...
Following the declaration last week that it is to invest in the
food enzyme side to its business, Danish enzyme company Novozymes
yesterday reported 'the best year ever' for 2002 with sales rising
7 per cent from DKK 5,271...
Strong phytosterol sales in the first quarter for Canadian company
Forbes Medi-Tech doubles first quarter revenues from last year. The
company reported revenue of C$2.4 billion (€1.6bn), up from C$1.2
billion in the comparable period...